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Abstract 
The Hap2/3/4/5 complex is a heme-activated, CCAATT binding, global transcriptional 
activator of genes involved in respiration and mitochondrial biogenesis in the yeast species 
Saccharomyces cerevisiae. Hap4 is the regulatory subunit of the complex and its levels 
determine the activity of the complex. Hap4 is known to play a signaling role in response to 
environmental conditions; however, little is known about the regulation of Hap4 levels or how it 
responses to a cell’s functional state. The activity of the Hap2-5 complex is known to be reduced 
in respiratory-deficient cells. In Liu Lab, it has previously been found that a link between Hap4 
stability, mediated through 26S proteasome-dependent degradation, and dependence on 
mitochondrial functional state plays a regulatory role on downstream targets of the Hap complex. 
However, the mechanism behind this regulation is still largely unknown. In normally functioning 
yeast cells, Hap4 is a highly unstable protein with a half-life of ~10 min. We have observed that 
loss of mitochondrial DNA in respiratory deficient rho0 cells has a role in the further 
destabilization of Hap4 to a half-life of ~4 min through the ubiquitin-proteasome pathway. 
Through the screening of a collection of mutants defective in E2 ubiquitin-conjugating enzymes, 
we show that Hap4 is greatly stabilized in ubc1Δubc4Δ double mutant cells. We also show that 
Hap4 stabilization in the ubc1Δubc4Δ mutant leads to increased activity of the Hap2-5 complex, 
indicating that mitochondrial biogenesis in yeast is regulated by the functional state of 
mitochondria through ubiquitin/proteasome-dependent degradation of Hap4. Furthermore, 
studies on Hap4 mutants involving two highly conserved cysteine residues led to a proposed 
mechanism behind the regulation of Ubc4 activity towards Hap4 in response to changes in the 
cellular redox state. 
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Introduction 	  
Saccharomyces cerevisiae as a model system 
As one of the best-studied eukaryotic organisms, yeast is a major research reagent in 
biological sciences. The duplicity of yeast, being one of the simplest eukaryotes, with genetic 
complexity marginally greater than that of most prokaryotes (Sherman, 2002), while 
simultaneously exhibiting high conservation of genes relative to mammalian cells, makes them 
an invaluable model organism (Botstein, Chervitz, & Cherry, 1997). The budding yeast species 
Saccharomyces cerevisiae is a well-established model organism in biology. As a non-pathogenic, 
fast growing, readily and affordably available yeast species, it is a highly convenient model to 
use in research (Sherman, 2002). Furthermore, protein structure homologies to mammalian 
proteins, ease of manipulation, and high experimental pliability make S. cerevisiae an 
archetypical model for research delving into the fundamental questions in biological sciences. 
In 1996, the complete DNA sequence of S. cerevisiae’s ~6000-gene genome was released 
in electronic form, making it the first eukaryotic species to have its genome completely 
sequenced (Goffeau, et al., 1996). This pioneering event led to the use of S. cerevisiae as a 
“model organism” for interpreting and understanding mammalian DNA sequences (Botstein, 
Chervitz, & Cherry, 1997). The numerous structural and functional similarities in the genes and 
their protein products encoded in S. cerevisiae’s genome to those of higher eukaryotes make 
yeast a time and money efficient avenue for gaining insight into cellular mechanisms of higher 
organisms. Over the years, the worth of S. cerevisiae has been further established, with it acting 
as a valuable model for delving into underlying mechanisms of disease states in higher 
eukaryotes.  
	  	   2	  
Yeast’s high experimental pliability allows for ease and comfort in the discovery process. 
Its aptitude at up-taking and expressing genes through DNA transformation, which can either be 
integrated into the yeast genome or exist as a multi- or single-copy replicative molecule in the 
nucleus, has played a sizeable role in their usefulness as a system by providing means for in-
depth studies of genes and the proteins they encode (Mumberg, Muller, & Funk, 1995) (Botstein, 
Chervitz, & Cherry, 1997). The well-defined genome of S. cerevisiae and protein homologies 
pairs wonderfully with this system, allowing for experiments on gene regulation, protein assay, 
genetic screening, random and targeted mutagenesis of specific genes, complete removal or 
“knock-out” of targeted genes. All of these approaches have the capability of further illuminating 
life on a molecular level.  
The Metabolism of a Facultative Aerobe 
 Metabolism is the combination of anabolic and catabolic biochemical pathways for the 
building and breaking down of biomolecules in a cell. Energy generation and carbon metabolism 
are intimately connected in eukaryotic cells, with exothermic change from catabolic processes 
often driving endothermic anabolic processes (Walker, 1998). The pathways behind carbon 
metabolism are highly structured and complex, being mediated through a series of tightly 
regulated branching enzymatic reactions. In yeast, carbon metabolism is intrinsically linked to 
cell growth and proliferation as well as to basic cellular functions and vitality through energy and 
metabolite production.  
S. cerevisiae is a facultative aerobe. In the presence of a preferred carbon source such as 
dextrose (glucose), it prefers fermentative metabolism through glycolysis and ethanol formation 
over respiratory metabolism and oxidative phosphorylation. Through evolutionary innovation, 
facultative aerobes have aquired the ability to utilize ethanol produced by fermentation as a 
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carbon source by switching to aerobic respiration when fermentable carbon sources are depleted 
(Botstein, Chervitz, & Cherry, 1997). The overview or these two pathways is shown in Figure 1 
and a brief outline will be given for understanding of the key factors regulating these two 
metabolic pathways.  
	  
Figure 1: Fermentation and Aerobic Respiration 
This model summarizes the two main metabolic pathways of facultative aerobes: 
Fermentative metabolism via glycolysis and fermentation and aerobic respiration via 
the Tricarboxylic Acid (TCA) cycle and the Electron Transport Chain (ETC). These 
two pathways are linked at two steps: with the conversion of pyruvate and/or ethanol to 
Acetyl-CoA, which is oxidized through the TCA cycle.   	  
During fermentative metabolism, glucose is broken down through glycolysis, a 
ubiquitous catabolic pathway, with a title literally meaning, “splitting of sugar.” In this pathway, 
which occurs in the cytosol, the six-carbon sugar glucose is broken down into two three-carbon 
molecules of pyruvate through ten enzyme-catalyzed reactions. This process provides part of the 
total cellular energy, producing two adenosine triphosphates (ATP) per glucose molecule by way 
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of substrate level phosphorylation. In the sixth step of glycolysis, the oxidized form of 
nicotinamide adenine dinucleotide (NAD+) is reduced to NADH by the transfer of hydrogen 
from glyceraldehyde phosphate by the enzyme glyceraldehyde 3-phosphate dehydrogenase. The 
overall reaction of glycolysis thus produces two moles of ATP, two moles of pyruvate, and two 
moles of the reduced NADH from one mole of glucose. 
For continuation of glycolysis, NAD+ must be regenerated through oxidation of the 
NADH produced by glycolysis. S. cerevisiae utilize alcoholic fermentation, in which pyruvate is 
converted to ethanol and carbon dioxide for the regeneration of NAD+ (Morton, 1980). This 
occurs in a two-step reaction whereby pyruvate is first decarboxylated by the enzyme pyruvate 
decarboxylase to form acetaldehyde, which is then reduced by NADH to form NAD+ as 
catalyzed by a second enzyme, alcohol dehydrogenase (Walker, 1998). Glycerol is also 
generated in this pathway from dihydroyacetone phosphate and later, as a non-fermentable 
carbon source, can be utilized in respiration (Morton, 1980).  
Aerobic respiration occurs in the mitochondria. As the catabolic process with the highest 
efficiency for ATP production, it is the principal metabolic pathway for Gibbs free energy 
production in most eukaryotic cells (Raghevendran, Patil, Olsson, & Nielsen, 2006). The overall 
pathway can be broken down into two metabolic pathways: the citric acid cycle, also known as 
the Tricarboxylic acid (TCA) or Krebs cycle, and the mitochondrial electron transport chain 
(ETC). During respiration NADH produced in the TCA cycle is oxidized by oxygen through the 
electron transport chain with concomitant generation of a proton (H+) gradient across the 
mitochondrial inner membrane, which drives ATP production through the F1F0-ATPase.  
In 1937, Hans Krebs provided the early insights that led to the historical discovery of the 
circular pathway whereby the acetyl group of acetyl-CoA is oxidized into two molecules of 
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carbon dioxide through a series of eight highly conserved enzymatic reactions (Krebs, 1937). An 
overview of the TCA cycle with these eight enzymes and the 13 nuclear genes in S. cerevisiae 
that encode them are shown in Figure 2.  	  
 
Figure 2: The TCA Cycle in S. cerevisiae 	  
A diagram of the TCA cycle intermediates and the yeast genes encoding the enzymes that 
catalyze the reactions. Substrates are shown in bold, while genes encoding the TCA cycle 
enzymes are shown in uppercase italic font. Of these enzymes, those with a rate-controlling role 
of the cycle are denoted by a line beneath their gene name.   
 
 The first substrate of the cycle, acetyl-CoA, can be produced from pyruvate through 
oxidative decarboxylation by the multi-enzyme complex pyruvate dehydrogenase in the 
mitochondria matrix. This is the linking step between glycolysis and the TCA cycle. However, in 
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yeast, acetyl-CoA is largely synthesized from ethanol produced during alcoholic fermentation. 
This occurs by way of three enzyme-regulated steps whereby ethanol is oxidized to 
acetaldehyde, which is sub-sequentially converted to acetic acid. Acetic acid is, in turn, 
converted to acetyl-CoA through a reaction requiring ATP.   
  The FADH2 and NADH produced in the TCA cycle act as electron carriers and are 
important in providing electrons for the next step of respiration, the electron transport chain 
(ETC), which harnesses free energy for the formation of ATP via oxidative phosphorylation. 
ATP synthesis occurs in the matrix of the mitochondria, where mobile and integral protein 
complexes act as electron carries, transporting electrons from NADH and FADH2 to a final 
electron acceptor. In the case of aerobic respiration, this is O2. During this transfer, the electrons 
are shuttled from redox centers with more negative reduction potentials to those of more positive 
and relative greater values. These values correlate to greater affinity for electrons, thus this 
shuttling produces free energy as overall exergonic process (Voet, Voet, & Pratt, 2010).  
In the ETC, there are four protein-lipid enzyme complexes located in the mitochondrial 
inner membrane containing flavins, quinoid compounds, and transition metal compounds, which 
act as electron carriers through redox reactions. In mammalian cells, these enzymes and their 
associated electron carriers are titled: complex I (NADH:ubiquinone oxidoreductase), complex II 
(succinate: ubiquinone oxidoreductase or succinate dehydrogenase), complex III 
(ubiquinol:ferrocytochrome oxidoreductase), and complex IV (cytochrome c oxidase). Electrons 
enter the electron transport chain through the oxidation of NADH to NAD+ at Complex I and 
FADH2 to FAD+ at Complex II, the latter which is also the sixth enzyme in the TCA cycle. 
Complex I of mammalian cells is composed of 46 different subunits, 7 of which are encoded by 
mitochondrial DNA (Vilain, et al., 2012). Interestingly, yeast cells do not contain these multi-
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subunit NADH-quinone oxidoreductases, rather they have a single protein, NADH 
dehydrogenase encoded by NDI1, which transfers electrons from NADH to ubiquinone in the 
respiratory chain without pumping protons (Vilain, et al., 2012). 
The ETC is linked to ATP synthesis through a theory proposed by British biochemist, 
Peter Michell in 1961, titled the chemiosmotic theory (Mitchell, 1978). This theory, which won 
Michell the Nobel Prize in Chemistry in 1978 “for his contribution to the understanding of 
biological energy transfer” (Nobel Media), was first received with much skepticism, but came to 
be accepted as one of the fundamental processes in all living systems from plants to humans. It 
states, the proteins of electron transport and ATP-synthesizing systems are localized in a 
membrane with a well-defined orientation and are functionally linked to a directional transfer of 
protons (H+), across the membrane (Mitchell, 1978). In eukaryotes, this occurs in mitochondria, 
via pumping of protons from the matrix into the intermembrane space at complexes I (except in 
yeast and other fungi), III, and IV, creating an electrochemical proton gradient across the inner 
mitochondrial membrane, the latter is then harnessed by the F1F0-ATP synthase for the 
production of ATP. 
As shown in Figure 1 fermentation and aerobic respiration each require their own 
enzymatic mechanisms and cellular machinery. Thus, the switch between fermentation and 
respiration requires a remodeling of gene expression, resulting in a characteristic growth pattern 
titled “diauxic shift” (Santangelo, 2006) (DeRisi, Lyer, & Brown, 1997). As the title implies, the 
diauxic shift refers to a two-sided curve that reflects the cells growth pattern as cells utilize a 
preferred carbon source first and then undergo remodeling of their metabolic pathways for the 
use of the second, and less preferred carbon source (Walker, 1998). In S. cerevisiae, this 
metabolic remodeling involves the use of non-fermentable carbon sources, such as lactate, 
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ethanol, glycerol, and pyruvate in respiration. This metabolic switch is regulated in response to 
external glucose levels, in a method that adjusts the energy metabolism in a process that is 
generally referred to as glucose repression (Rodrigues, Ludovico, & Leao, 2006).  
 By definition, glucose repression refers to the phenomenon whereby cells grown on 
glucose repress the expression of a large number of genes that are required for the metabolism of 
alternate carbon sources (Trumbly, 1992). Due to a preference for fermentative metabolism in S. 
cerevisiae, glucose repression affects the expression of enzymes required for metabolism of non-
fermentable carbon sources as well as enzymes involved in respiration and mitochondrial 
biogenesis (Rolland, Winderickx, & Thevelein, 2002). This is a highly regulated process, 
involving gene and protein regulation at multiple levels in a number of signal transduction 
pathways. Energy metabolism is dependent on a few transcription factors, which regulate cellular 
processes by controlling the expression of multiple genes involved in a given cellular  pathway. 
Transcription factors are key elements in regulating the expression of target genes (Fendt & 
Uwe, 2012). One of these transcription factors in S. cerevisiae is the Hap2-5 complex, which is 
an essential part of yeast’s metabolic remodeling when entering respiratory growth and is 
responsible for the activation of roughly a hundred genes involved in respiration and other 
metabolic functions (Pinto & McNabb, 2005). 
The Hap2/3/4/5 Complex 
The majority of the genes encoding mitochondrial proteins are encoded in the nuclear 
genome. In yeast, the expression of these genes becomes de-repressed during the diauxic shift. 
This de-repression is principally regulated by a family of heme-activated proteins, known as 
Hap proteins (Liu & Butow, 1999). The Hap proteins are transcription factors that bind to DNA 
at distinct upstream activation sites (UAS) of genes involved in respiration and regulate their 
	  	   9	  
transcription. These proteins are mainly responsible for the transcriptional regulation of 
respiration, and do so by controlling the expression of multiple genes encoding the proteins 
involved in respiration, such as components of the electron transport chain and the enzymes of 
the TCA cycle.  
As their names imply, Hap proteins’ activity depends on the cofactor heme. Heme is an 
iron-containing heterocyclic prosthetic group with electron carrying properties and a high 
affinity for oxygen. Its cellular concentration is linked to oxygen availability through its 
biosynthesis, which is oxygen-dependent (Kwast, Burke, & Poyton, 1998). Heme is known to 
regulate the activity of a diverse group of proteins, with heme-regulated signal transducers being 
found in organisms ranging from bacteria to humans (Zhang, et al., 2007). Heme is involved in 
oxygen sensing, acting as a positive modulator for the transcription of the aerobic genes and as a 
negative modulator for the transcription of the hypoxic genes (Kwast, Burke, & Poyton, 1998). 
Therefore, heme acts as an intermediary in the regulation of the expression of genes involved in 
respiration and thus oxidative phosphorylation. In S. cerevisiae, this regulation is accomplished 
through the HAP family. There are two components to the HAP system: Hap1 and the 
Hap2/3/4/5 complex. Together these two transcription factors represent an important mechanism 
for global control of the expression of key components in respiratory metabolism. 
Hap1 was first identified as an activator of the hypoxic gene iso-cytochrome C gene 
(CYC7) in 1969 and termed CYP1. However, the gene was later re-designated based on the 
discovery in 1986 that it was the same protein reported as Hap1, an activator of CYC1 expression 
(reviewed by Kwast, Burke, & Poyton, 1998). Analysis of the upstream regulation of CYC1 
expression led to the identification of two distinct upstream activation sequences, UAS1 and 
UAS2 (Pfeifer, Prezant, & Guarente, 1987) (Lalonde, Arcangioli, & Guarente, 1986). Upstream 
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activation sequences (UAS) are cis-acting elements upstream of TATA boxes, which act as a 
primary cellular loci for gene-specific regulation (Lalonde, Arcangioli, & Guarente, 1986). Hap1 
is responsible for the regulation at UAS1 of the CYC1 gene and it is also targeted to genes 
encoding the proteins involved in heme biosynthesis, electron transfer reactions and controlling 
oxidative damage (Gaisne, Becam, Verdiere, & Herbert, 1999) (Zhang & Hach, 1999). The other 
component of the Hap family, the Hap2-5 complex, regulates the transcription of genes involved 
in mitochondrial biogenesis and oxidative phosphorylation by acting on the CCAAT element .  
	  
Figure 3: Hap2-5 Target Genes 
A model for the role of the Hap Pathway in controlling the expression of genes involved in the TCA 
cycle and ETC. When the Hap pathway is activated the expression of key components of respiration 
increases and mitochondrial function and biogenesis is optimized as under the control of the Hap 
pathway.  
 
As a global transcriptional activator, the Hap2-5 complex is responsible for the activation 
of about 100 genes responsible for respiration and other metabolic functions (Pinto & McNabb, 
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2005). Included in this group are genes encoding key enzymes in oxidative phosphorylation and 
mitochondrial biogenesis (Figure 3). These are required for respiration, with deletion or 
malfunction of any one of these subunits rendering cells unable to grow on non-fermentable 
carbon sources (Olesen, Hahn, & Guarente, 1987) (Bourgarel, Nguyen, & Bolotin, 1993). In de-
repressed cells that are grown in low glucose media and that contain respiratory-competent 
mitochondria, the Hap2-5 complex is required for transcriptional activation of genes encoding 
key enzymes of the TCA cycle, including: KGD1 (encoding the E1 component of α-ketoglutarate 
dehydrogenase), IDH1 and IDH2 (encoding the subunits of isocitrate dehydrogenase), SDH1 
(encoding the flavoprotein component of succinate dehydrogenase), FUM1 (encoding the 
enzyme fumarate hydratase), and MDH1 (encoding malate dehydrogenase) (Liu & Butow, 
2006). Additionally, CYC1 (encoding cytochrome c, isoform 1), CYT1 (encoding cytochrome 
c1), CIT1 (encoding the mitochondrial isoform of citrate synthase), KGD2 (encoding the E2 
component of mitochondrial α-ketoglutarate dehydrogenase complex), QCR8 (encoding a 
subunit of the ubiquinone:cytochrome c oxidoreductase complex) and SDH2 (encoding the iron-
sulfur protein subunit of the succinate dehydrogenase complex) are also reported to be target 
genes of the Hap2-5 complex (Schüller, 2003).  
 The Hap2-5 complex binds to the 5’-CCAAT-3’ consensus sequence in the promoter of 
target genes and is thus also known as the CCAAT-binding factor (CBF) complex in yeast. 
CBF’s exist in many species and represents a conserved mechanism of heterologous gene 
regulation (Mantovani, 1999). The type and number of genes regulated by CBF’s vary, but the 
5’-CCAAT-3’ consensus sequence that they bind to is conserved (Mantovani, 1999). Hap2, 
Hap3, and Hap5 each contain a core domain that is highly conserved during evolution and is 
required for DNA binding and subunit association. Among the four protein of the Hap2-5 
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complex, Hap2 was discovered first and its identification led to the discovery of Hap3 (Olesen, 
Hahn, & Guarente, 1987). Hap5 is required for interaction between Hap2 and Hap3, and thus the 
assembly and DNA-binding activity of the complex (McNabb, Xing, & Guarente, 1995) (Pinto 
& McNabb, 2005). The DNA binding domain of the Hap2-5 complex is located on the Hap2 and 
Hap3 subunits. These two subunits are functionally conserved in mammalian CBF (McNabb, 
Xing, & Guarente, 1995) (Xing, Fikes, & Guarente, 1993). 
On the other hand, the Hap4 subunit of the complex is not required for DNA binding, but 
it is the regulatory subunit, with its levels determining the activity of the complex (Forsburg & 
Guarente, 1989)(Olesen & Guarente, 1990). In cells grown in low levels of glucose, HAP4 
expression is induced, leading to high levels of Hap4 and its migration into the nucleus, and the 
resultant activation of the Hap2/3/4/5 complex (as shown in Figure 5) (Liu Lab Unpublished 
Results). This activation is accomplished by two transcriptional activation domains one in the 
carboxyl- and one in the amino-termini (Stebbins & Triezenberg, 2004) (Forsburg & Guarente, 
1989). The C-terminus contains a highly acidic region, a common characteristic of 
transcriptional activators (Forsburg & Guarente, 1989).  HAP4 expression is affected by the 
functional states of the mitochondria. In cells with robust mitochondrial respiratory activity, 
Hap4 expression is high, while in cells with dysfunctional mitochondria, for example due to loss 
of mitochondrial DNA as in rho0 petites, Hap4 expression is reduced (Ozcan, Dover, & Johnston, 
1998).  
As the regulatory subunit of the complex, Hap4 is an ideal point of focus for the study of 
regulation of the Hap pathway. Despite its central role in respiratory metabolism and 
mitochondrial biogenesis, little is known about the mechanism behind HAP4 expression and how 
Hap4 levels are regulated. Further studies on the regulation of Hap4 levels could provide new 
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insights into the regulation of this important pathway. Regulation of Hap4 protein levels is the 
focus of this thesis.  
Mitochondrial Biogenesis 
	  
Mitochondria are thought to have once existed as independent organisms. Their evolution 
into their current role as a cellular organelle is explained by the endosymbiotic theory, which 
postulates that mitochondria began as independent bacteria that were ingested through 
endosymbiosis. One important piece of evidence in support of this theory is that mitochondria 
still contain their own circular genome, known as mtDNA. Though most of the proteins utilized 
in the mitochondrial pathways are encoded in the nuclear genome, mtDNA contains 15,000-
18,000 base pairs depending on the species. These base pairs are responsible for approximately 
thirteen protein-encoding genes required for respiration. However, the majority of genes 
involved in respiration are not located in mtDNA and are instead encoded in the nuclear genome. 
The remainder of the mitochondrial genome encodes the machinery necessary for translation of 
mtDNA. Mitochondrial number and function are altered in response to external stimuli; this is 
mediated through coordinated expression of genes encoded in the nuclear and mitochondrial 
genome. This coordinated expression is regulated by transcription/replication factors such as the 
Hap2-5 complex.  
From the genetic standpoint, the respiratory chain is a unique cellular structure, being 
formed by means of the complementation of two separate genetic systems: the nuclear genome 
and the mitochondrial genome (Zeviani & Donato, 2004). Thus, one fundamental question in the 
biological sciences is how the coordinated expression between these two genomes occurs. For 
coordinated expression, cells must have a mechanism of sensing the state of the mitochondria 
and leading to changes in nuclear gene expression accordingly. The budding yeast is an ideal 
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organism for studying the signal transduction pathways involved in mitochondrial biogenesis: it 
is viable in rho0 (no mtDNA) and rho- (mutant mtDNA) states. Mitochondrial biogenesis is often 
studied through research on the regulation of key factors controlling the biosynthesis of the 
enzyme complexes of oxidative phosphorylation. This is often carried out by the same factors 
regulating the expression of genes implicated in glucose derepression, such as the Hap proteins.  	  
The Ubiquitin-Protease System 
Protein levels are controlled at transcriptional and post-translational levels. The ubiquitin-
protease system (UPS) is the main degradation pathway in the cytosol in all eukaryotes and is 
key in post-translational regulation of protein levels (Seufert & Jentsch, 1990). Protein 
degradation is the breaking down of proteins via proteolysis, namely the breaking of peptide 
bonds. This is an important regulatory process that allows cells to dispose of mis-folded or 
damaged proteins, as well as to control the concentration of proteins within the cell by selective 
degradation. Selective degradation is key to the control of cellular signal transduction and 
regulation of cellular pathways by modulation of the levels of key regulatory factors 
(Hochstrasser, 1996). Through this method, the UPS controls multiple pathways by regulating 
the stability of target proteins that govern specific cellular function, including the cell cycle, class 
I antigen processing, transcriptional regulation, signal transduction pathways, receptor down 
regulation, and receptor- mediated endocytosis (Hochstrasser, 1996). Malfunction in this system  
leads to a number of disease states and pathological disorders including Alzheimer’s, 
Huntington’s, Parkinson’s, and malignant transformation linked to cancer (Davies, Sarkar, & 
Rubinsztein, 2007) (Schwartz, 1999). Understanding of the factors regulating the UPS in 
targeted degradation thus has practical application in the cellular viability and disease 
mechanism.  
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In 2004, Aaron Ciechanover, Avram Hershko, and Irwin Rose won the Nobel Prize in 
Chemistry for their work on the discovery of the UPS. The UPS involves poly-ubiquitination of 
proteins through covalent binding of ubiquitin molecules to a target protein in an ATP-dependent 
manner at specific lysine residues for its subsequent degradation through the 26S proteasome 
(Figure 4) (Tongaronkar, Li, Lambertson, Ko, & Madura, 2000). Three types of enzymes 
catalyze the covalent attachment of ubiquitin to its target protein, which, with increasing 
specificity, ensure a system with the high degree of selectivity toward its many substrates 
(Ciechanover, Orian, & Schwartz, 2000). These are: ubiquitin-activating enzymes (E1), 
ubiquitin-conjugating enzymes (E2) and ubiquitin ligases (E3).  	  
 
Figure 4: The Ubiquitin-Proteasome System 
A simplified model of the Ubiquitin-Proteasome System. Whereby, a target protein is 
polyubiquinated by repeated cycling through a three enzyme (E1, E2, and E3) cascade for its 
eventual targeting to the 26S-Proteasome for degradation.	  
 
The UPS starts with ubiquitin’s activation by E1 in an ATP-dependent reaction, which 
resulting in the linking of ubiquitin to E1 by means a high-energy thioester bond at a highly 
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conserved cysteine residue. Ubiquitin is then transferred to E2, where it forms a thioester bond at 
a conserved cysteine residue on the surface of E2. Then, ubiquitin is transferred to a targeted 
protein substrate as facilitated by E2 and E3, which together catalyze the isopeptide bond 
formation between ubiquitin and a lysine residue(s) on the substrate (Hochstrasser, 1996). This 
enzyme cascade is repeated to form a chain of isopeptide-linked ubiquitin on the substrate, a 
structure that targets the protein to the 26S proteasome complex, a large, multi-protein complex  
that catalyzes proteolysis of the ubiquitinated protein.  
Polyubiquitination of target proteins is a highly regulated process and varies greatly 
among substrate proteins. While much is known about the overall mechanism of the UPS, the 
exact signals that target specific proteins for degradation remain to be discovered in many signal 
transduction pathways. A few of the known factors that affect the regulation of protein turnover 
include: phosphorylation as a signal for ubiquitination (as in the case of Mos, oocyte protein 
kinase and beta-catenin and NF-κB regulatory protein IκBα), glucose ( as with fructose 
bisphosphate in yeast), glycosylation (for the elimination of denatured glycoproteins), amino 
acid starvation (as for Gcn4 a transcription factor in yeast), and even red light ( seen in 
Phytochrome, a plant light-responsive receptor) (Hochstrasser, 1996) (Hunter, 2007) (Orford, 
Crockett, Jensen, Weissman, & Byers, 1997).  
The enzymes of the UPS are highly conserved in all eukaryotic cells, though the number 
and variety is more complex in mammalian cells as compared to lower eukaryotic organisms. 
Though there are many homologues between yeast and mammalian E2’s, the terminology is 
completely different and does not reflect the functional or structural homologies (Glickman & 
Ciechanover, 2002). In S. cerevisiae there exists a single E1, designated (UBA1), thirteen E2’s 
(UBC), and an unknown number of E3’s. Of the thirteen identified E2’s in the yeast genome, 
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two, Ubc9 and Ubc12, do not conjugate to ubiquitin, but are nonetheless considered part of the 
UBC family.  
As stated previously, Hap4 levels are dramatically decreased in cells with dysfunctional 
mitochondria as compared to those with robust mitochondrial respiratory activity (Figure 5). 
This change in protein level is not fully explained by HAP4 transcription, indicating that Hap4 
might be subject to posttranslational regulation (Capps, 2011) (Ozcan, Dover, & Johnston, 
1998).  
 
Figure 5: Hap4 Activity in Response to Dysfunctional Mitochondria 
A model for the regulation of the Hap2-5 complex. To the right are de-repressing conditions 
under which Hap4 levels are high, leading to its migration into the nucleus for interaction with 
the Hap2/3/4/5 complex for its activation and, consequently, the transcription of genes involved 
in respiratory growth. To the left are repressing conditions under which Hap4 is inhibited by high 
glucose and some unknown mechanism in cells with dysfunctional mitochondria, leading in turn 
to a downregulation of the HAP pathway and respiratory growth. 
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Materials and Methods 
Media and Growth Conditions 
 Yeast strains were grown in media at 30˚C. The media used were: YPD medium (1% 
Bacto-yeast extract, 2% Bacto-Peptone, 2%dextrose), YNB medium (0.67% yeast nitrogen base) 
supplemented with 1% Casamino Acids, 5% or 2% dextrose (YNBcasD) or 2% raffinose 
(YNBcasR) (Amberg, Burke, & Strathern, 2005). For plates, agar was used as well (2% Bacto-
Agar). When required, tryptophan (30 mg/liter) was added to YNBcasD or YNBcasR media to 
allow trp1 mutant cells to grow. 
 
Yeast Strains 
 All yeast strains used in this project were of one of two parent strain backgrounds: Y000  
(MATa his3-Δ200 leu2-3,2-112 lys2-801 trp1-1(am) ura3-52) or BY4741 (MATa ura3Δ leu2Δ 
his3Δ1 met15Δ). Specific strains that were used in rho0 mutant generation and plasmids for  
transformation were all acquired from Liu Lab stock.  
Yeast Expression Plasmids for Constructing Epitope Tagged Proteins 
 In this project, two yeast expression vectors were used as plasmid templates: pRS414 
(TRP1) and pRS416 (URA3) (Mumberg, Muller, & Funk, 1995). The gene encoding the protein 
under investigation was fused at its 3’-end, to a DNA sequence encoding a 10-alanine linker and 
a epitope tag (-myc3 or –HA3).  
Generation of strains lacking mtDNA (rho0) 
 Respiratory capable, rho+ yeast strains were treated with ethidium bromide (EB), a 
mutagenic known to preferentially intercalate into mtDNA. To generate rho0 cells, rho+ cells 
were grown in YPD medium supplemented with 15 ug/ml EB at 30˚C to saturation. Cultures 
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were streaked out on YPD plate to obtain single colonies. Single colonies were then streaked on 
to YPGlycerol plates and YPD plates. Cells lacking mtDNA were selected for by growth 
phenotype, as rho0 cells unable to form colonies on YPGlycerol plates (due to inability to 
undergo respiration). Loss of mtDNA was further verified by 4,6-­‐diamidino-­‐2-­‐phenylindole 
(DAPI) staining of individual colonies and fluorescence microscopy using MetaMorph computer 
program. 
Yeast High-efficiency Transformation 
 Fresh cells were inoculated in rich YPD media (or appropriate selective media) using a 
sterile loop to OD ~0.2. Cells were incubated 30˚C for 3-5 hours with agitation. Cells were 
harvested by centrifuge and re-suspended in 0.1M LiOAc. Cells were incubated with plasmid 
DNA and transformation mix (single strand DNA, LiOAc, PEG) at 42°C for 60 minutes. Cells 
were then plated on selective media to select for transformants.  
Protein Collection  
 Yeast strains were transformed with plasmids containing the gene encoding the protein of 
interest with an epitope tag. Cells were lysed using extraction buffer (18.5% 10N NaOH, 7.4% 
beta-mercaptoethanol) on ice for 10-30 min. Total cellular proteins were collected through 
precipitation using 8% trichloroacetic acid. Pellets were neutralized using 1M unbuffered Tris 
and boiled in SDS-PAGE loading buffer for 4 min. For samples where cysteine bond formation 
was examined, samples were collected using extraction buffer lacking β-Mercaptoethanol. 
Immunoblotting (Western Blotting)  
Proteins were separated using sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE). Protein loading was balanced based on the OD600  readings of cultures before 
collection. For samples in which cysteine bond formation was to be examined, urea (8M) was 
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used for denaturing and DTT was omitted to prevent reduction of disulfide bonds. Proteins were 
transferred to nitrocellulose membranes by electroblotting. For immunoblotting, nitrocellulose 
membranes were probed with primary antibody, either rat monoclonal high affinity anti- HA IgG 
or mouse monoclonal anti-Myc anti-body in 1X TBS-Tween solution with 5% milk powder. 
Membranes were then probed with HRP-conjugated goat anti-rat, goat anti-mouse, or goat anti-
rabbit antibody. Chemiluminescence was produced using the ECL reagent and images were 
captured using the Bio-Rad Chemi-Doc system. For loading controls, membranes were stripped 
in deprobing buffer (67.5 mM Tris-HCl, pH 6.7, 2% SDS, 0.08% β-mercaptoethanol) at 60°C for 
30 min and reprobed with rabbit polyclonal anti-Pgk1antibody (ubiquitous and stable protein 
phosphoglycerate kinase) .  
 
PCR mutagenesis of Cysteine to Serine mutant of Ubc4  
Polymerase Chain Reaction (PCR) SOEing was utilized to carry out site-directed 
mutagenesis. To this end, primers were designed with nucleotide mismatches for the introduction 
mutation of cysteine residue 22 to serine (C22S) or cysteine residue 108 to serine (C108S) by 
point mutation of guanidine to cytosine (Figure 6).  Mutants were confirmed by sequencing. 
Plasmids containing confirmed mutations were transformed into respective yeast strains and 
selected for as outlined in Yeast High Efficiency Transformation.  
HS OH
O
NH2
HO OH
O
NH2
Cysteine Serine
TGT TCTCodon:
Amino Acid:
Mutanagenesis
 
Figure 6: Point Mutagenesis of Cysteine Residue to Serine 
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Cycloheximide Chase Analysis  
Cells were grown overnight in liquid YNBcas5%D or YNBcasRaff medium to log phase 
(OD600 0.6~0.8). Before cycloheximide treatment, 1.0 ml culture was collected as zero time 
point. Cycloheximide was used to inhibit protein synthesis by acting on the ribosome to prevent 
translation. At fixed time intervals (five or ten min.), 1.0 ml culture was collected for generating 
total cellular extracts. Proteins of interest were visualized by Immunoblotting. Two to three 
independent experiments were carried out and scrutinized for reproducibility. Quantification was 
carried out using Bio-Rad QuantityOne software and protein half-life (T1/2) was calculated using 
Microsoft Excel. 
 
β-Galactosidase Assay 
 Plasmids expressing a lacZ gene fused to the promoter of the gene under analysis were 
transformed into yeast strains. Cells were grown to undergo a minimum of six generations and 
collected at OD600 0.6-0.8. β-galactosidase assays were carried out as described (Amberg, Burke, 
& Strathern, 2005). Briefly, cells were collected by centrifugation and resuspended in breaking 
buffer (100 mM Tris-HCl, pH 8, 1 mM dithiotreitol, 20% glycerol). Samples were stored at -20 
°C until assay was conducted. For assays, cells were thawed on ice and treated with 1 mM 
phenylmethylsulfonyl fluoride [PMSF] to prevent protein degradation. Total cellular extracts 
were obtained by vortexing in the presence of glass beads (0.45-0.50 mm). β-galactosidase 
activities of a lacZ reporter gene were reported in nanomoles of colorimetric product o-
nitrophenyl-β-d-galactopyranoside [ONPG] per milligram of protein per minute. Specific activity 
was calculated in relation to the total protein amount in the initial extract, determined using the 
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Bradford assay. For each plasmid-strain combination, two or three independent cultures were 
grown and β-galactosidase activities were determined. 
 
	  	   23	  
Results 	  
Preliminary Findings from Liu Lab 
As reported by Denise Capps in her thesis for the requirements for a degree of Master of Science 
in Biological Sciences at the University of New Orleans (Capps, 2011). 
Mitochondrial Functional State Regulates Hap2-5 Pathway Activity 
 In previous experiments from Liu Lab, it has been reported that expression of KGD1, a 
Hap2-5 complex reporter gene, is reduced in rho 0 cells. The KGD1 activity is similar to that seen 
in a hap4 deletion mutant, where the pathway is inactivated, suggesting the Hap2-5 pathway is 
down regulated in response to compromised mitochondrial function. The promoter activity of 
Hap4 was also found to be down regulated in rho0 cells, however only a 2.5-fold decrease from 
rho+ to rho0 was observed, leaving the question of where the discrepancy in pathway activity and 
HAP4 expression is originating. Hap4 protein levels were examined using Western blotting and 
found to show a six-fold decrease from rho+ to rho0 cells. The discrepancy in HAP4 promoter 
activity and Hap4 protein levels suggest that Hap4 is subject to post-transcriptional regulation. It 
was then found that Hap4 is highly unstable in rho+ cells. In rho0 cells, Hap4 instability is 
further increased. Hap4 instability was found to be mediated through proteasome-dependent 
degradation. 
Goals of Research 
 The overall objective of my research is to understand the cellular mechanisms regulating 
the coordinated expression of genes involved in mitochondrial biogenesis and oxidative 
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phosphorylation between mitochondria and the nuclear genome. A fundamental question is how 
cells sense functional states of mitochondria and adjust nuclear gene expression accordingly, 
thus coordinating the expression of genes between the two genomes. Hap4, the regulatory 
subunit of the Hap2-5 complex in this pathway, is the focus of my study. More specifically, my 
central focus is on how Hap4 degradation is regulated through the Ubiquitin-Proteasome system 
and the mechanism underlying the increased degradation of Hap4 in rho0 cells.  
Research Results 
Hap4 has increased instability in rho0 cells, as compared to rho+ cells 
 Hap4 is a highly unstable protein (Capps, 2011). To confirm that Hap4 is further 
destabilized in cells lacking functional mitochondria, rho+ and rho0 cells containing a plasmid 
encoding 3xHA-tagged Hap4 were assayed for Hap4 stability using cycloheximide chase and 
immunoblotting. The results of this experiment are shown in Figure 7.  
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Figure 7: Analysis of Hap4 Stability by Cycloheximide Chase 
(A) Strains containing a HAP4-HA plasmid were assayed for Hap4 stability using cycloheximide 
chase and immunoblotting. (B) Hap4 levels in panel A were determined using Bio-Rad 
QuantityOne software and the half-life (T1/2) of Hap4-HA was calculated using Microsoft Excel. 	  
  
 Consistent with Denise Capps’s result, Hap4 is an unstable protein in cells with normal 
functioning mitochondria (rho+ cells), with an estimated half-life of ~10 minutes. In cells with 
dysfunctional mitochondria (rho0 cells), Hap4 is greatly destabilized, with an estimated half-life 
of ~4 min. Based on these results, it is clear that there exists some cellular mechanism by which 
Hap4 stability is regulated by the functional states of mitochondria.  
 
Hap4 is stabilized in a ubc1Δubc4Δ double mutant 
 To identify the ubiquitin-conjugating (Ubc) enzyme(s) responsible Hap4 degradation in 
rho0 cells, I analyzed Hap4 stability in a collection of fifteen strains lacking designated Ubc 
enzymes as described in Figure 8. To this end, all mutant strains were acquired from Liu Lab 
Yeast Stock and rho0 petite derivatives of the mutants were generated as described in Materials 
and Methods. These rho0 cells were transformed with plasmids encoding 3xHA-tagged HAP4 
and transformants were analyzed for Hap4 stability using cycloheximide chase. Figure 8 shows 
that only a ubc1 ubc4 double mutation greatly stabilizes Hap4, indicating that Ubc1 and Ubc4 
play a redundant role in mediating ubiquitin-proteasome dependent degradation of Hap4.  
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 Figure 8: Analysis of Hap4 Stability in ubc Mutants by Cycloheximide chase 
Rho0 wild-type and isogenic ubc mutant cells were grown in YNBcasR media to mid-log phase 
and Hap4 stability was analyzed by cycloheximide chase and immunoblotting. Pgk1 protein 
levels were determined using anti-Pgk1 antibody and included as loading controls.  
  
Hap4 stabilization in ubc1Δubc4Δ mutant cells under various conditions 
 We next examined the effect of a ubc1 ubc4 double mutation on Hap4 stability in rho+ cells 
grown in YNBcasR media and in both rho+ cells and rho0 cells grown in YNBcasD media. I 
found that Hap4 is stabilized in ubc1 ubc4 double mutant cells under all four conditions (rho+, 
rho0, YNBcasR, YNBcasD) (Figure 9). These data suggest that Ubc1 and Ubc4 play a house-
keeping role in turning over Hap4. However, they do not exclude the possibility that the activity 
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of Ubc1 and Ubc4 towards Hap4 is increased in response to a loss of mitochondrial respiratory 
function.  
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Figure 9: Hap4 Stability in ubc1Δub4Δ mutant 
Rho+ and rho0 wild-type and isogenic ubc1 ubc4 mutant cells were grown in YNBcasD or 
YNBcasR media and Hap4 stability was analyzed by cycloheximide chase and immunoblotting. 
Pgk1 was used as loading controls.  
 
Hap4 stabilization due to a ubc1Δubc4Δ double mutation correlates with increased 
expression of Hap2-5 target genes 
 Hap4 is stabilized in a ubc1 ubc4 double mutant, however the question remains of does 
Ubc1/4-dependent degradation of Hap4 affect pathway activity. To this end, the expression of 
two Hap2-5 target genes, KGD1 and SDH1, was analyzed in rho+ wild-type and isogenic 
ubc1Δubc4Δ double mutant cells grown in YNBcasD media. Figure 10 shows that expression of 
a lacZ reporter gene under the control of KGD1 or SDH1 promoter is increased ~6-fold in ubc1 
ubc4 double mutant cells compared to wild-type cells. To determine whether an increase in the 
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expression of KGD1- and SDH1-lacZ reporter genes in the ubc1 ubc4 mutant is Hap4-dependent, 
their expression was analyzed in a hap4 single mutant and a ubc1 ubc4 hap4 triple mutant. 
Figure 10 shows that a hap4 mutation largely abolishes increased expression of KGD1- and 
SDH1-lacZ reporter genes in the ubc1 ubc4 mutant. Together, these data indicate that Ubc1/4-
dependent degradation of Hap4 negatively regulates the expression of Hap2-5 target genes. 
0
20
40
60
80
100
120
140
160 WT
KGD1-lacZ SDH1-lacZ
hap4'
ubc1/4'
ubc1/4' hap4'
E-
ga
la
ct
os
id
as
e 
ac
tiv
ity
 (n
m
ol
s/
m
in
/m
g 
pr
ot
ei
n)
0
20
40
60
80
100
120
140
160 WT
KGD1-lacZ SDH1-lacZ
ubc1/4'
ubc1/4' hap4'
E
ga
la
ct
os
id
as
e 
ac
tiv
ity
 (n
m
ol
s/
m
in
/m
g 
pr
ot
ei
n)
 
 Figure 10: Hap2-5 Pathway Activity is Up-Regulated by Hap4 Stabilization 
Rho+ wild-type and isogenic hap4 single, ubc1/4 double and ubc1/4 hap4 triple mutant cells 
carrying either a KGD1-lacZ or a SDH1-lacZ fusion gene were grown in YNBcasD media and β-
galactosidase activities were determined as described in Methods and Materials.	  
 
Two cysteine to serine mutants of Ubc4 are functional based on their ability to restore 
robust cell growth to a ubc4 ubc5 double mutant 
 Ubc4 and Ubc5 share three highly conserved cysteine residues. Of the three, one is the 
catalytic residue and the other two serve no known function. Cysteine residues are among the 
least common amino acid residues and are known to be involved in sensing the redox 
environment of the cell. A loss in the mitochondrial respiratory function might affect the redox 
balance in the cell, which in turn might affect the activity of Ubc4 towards Hap4. To test this 
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possibility, the conserved non-catalytic cysteine residues at the 22nd and 108th positions of Ubc4 
were mutated to a serine residue and the resulting mutants will be referred to as C1S and C2S for 
C22S and C108S mutations, respectively. We determined whether Ubc4(C1S) and Ubc4(C2S) 
mutants are functional based on their ability to restore fast cell growth to a ubc4 ubc5 double 
mutant (Figure 11). A ubc5Δ single deletion mutant that expresses wild-type Ubc4 shows robust 
growth. In contrast, in cells lacking both Ubc4 and Ubc5, the growth is strongly reduced. In ubc4 
ubc5 double mutant cells transformed with a plasmid encoding myc-tagged UBC4, robust cell 
growth is largely restored. This growth is matched by the ubc4(C1S) and ubc4(C2S) mutants, 
indicating that these two mutants are functional. 
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ubc4/5'
vector
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pUBC4-myc3
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Figure 11: ubc4 Cysteine to Serine Mutant Functionality 
Plasmids encoding myc3-tagged UBC4 wild type, C1S or C2S mutant were transformed into a 
ubc4 ubc5 double mutant and transformants were grown on YNBcasD media. As controls, a 
ubc5 single and a ubc4 ubc5 double mutant each carrying an empty vector were also tested for 
growth. The picture was taken after 48 h. The slow growth phenotype seen in ubc4Δ ubc5Δ 
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double mutant cells carrying an empty vector is not shared with the strains transformed with a 
plasmid encoding any of the UBC4-myc3 (WT or mutant). 
 
The steady-state level of Hap4 is increased in ubc4(C1S) mutant 
 To determine whether the C1S and C2S mutations in UBC4 affect Hap4 stability, we first 
examined the effect of these two mutations on the steady-state level of Hap4. To this end, rho0 
ubc1 ubc4 double mutant cells co-expressing Hap4-HA and Ubc4-myc, ubc4(c1S)-myc or 
ubc4(C2)-myc were grown in YNBcasD or YNBcasR media and analyzed for Hap4 expression 
by SDS-PAGE and immunoblotting. Figure 12 shows that the C1S mutation, not the C2S 
mutation, significantly increases the steady-state level of Hap4, suggesting that the cysteine 
residue 22 might be required for Hap4 degradation.  
 
Figure 12: Hap4 Steady State Levels in ubc4 (Cys to Ser) Mutants 
 
Rho0 ubc1Δ ubc4Δ strain containing plasmids encoding HAP4-HA and UBC4 alleles as indicated 
were grown in dextrose or raffinose media and total cellular proteins was prepared using TCA 
precipitation. The steady-state level of Hap4 was analyzed using immunoblotting. Pgk1 protein 
levels were determined to show equal sample loading.    
   
 To determine whether the effect of the UBC4(C1S) mutant on Hap4 expression observed in 
Figure 12  is post-translational or transcriptional, I determined the activity of a HAP4-lacZ 
reporter gene, which provides information on HAP4 transcription, in ubc1 ubc4 double mutant 
cells expressing myc-tagged wild-type UBC4, a C1S or a C2S mutant. Figure 13 shows that the 
promoter activity of HAP4 is similar in cells expressing wild-type UBC4, the C1S or the C2S 
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mutant. The data in Figure 12 and 13 provide evidence for a post-transcriptional mechanism 
behind the increase in the steady-state level of Hap4 observed in the ubc4(C1S) mutant. 
 
Figure 13: HAP4-lacZ promoter activity in ubc4 (Cys to Ser) mutation 
 
Rho0 ubc1Δ ubc4Δ mutant cells containing plasmids encoding HAP4-lacZ and UBC4 alleles as 
indicated were grown in dextrose or raffinose media and media and β-galactosidase activities 
were determined as described in Methods and Materials. 
 
Hap4 is stabilized due to a ubc4(C1S) mutation  
 To confirm that Hap4 is stabilized in a ubc4(C1S) mutant, I determined Hap4 stability in 
ubc1 ubc4 double mutant cells expressing myc-tagged Ubc4 or a C1S mutant using 
cycloheximide chase. Hap4 is destabilized in ubc1 ubc4 double mutant cells transformed with a 
plasmid encoding UBC4-myc3 as compared to a control vector. In ubc1 ubc4 double mutant 
cells transformed with a plasmid encoding the C1S mutant allele, Hap4 is dramatically stabilized. 
This stabilization is comparable to that in the ubc1Δubc4Δ double mutant with a control vector. 
Together, these data suggest that the cysteine residue 22 of Ubc4 is required for its activity 
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towards Hap4.  
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Figure 14: ubc4(C1S) mutation leads to Hap4 stabilization 	  
Rho0 ubc1Δ ubc4Δ strain containing plasmids encoding HAP4-HA and UBC4 alleles as indicated 
were grown in raffinose media and Hap4 stability was analyzed by cycloheximide chase. Pgk1 
protein levels were determined to show equal sample loading.    
 
 
The ubc4(C1S) mutation affects Ubc4 modification 
 As a first step towards understanding the effect of a C1S mutation on Ubc4 activity, I 
determined whether the C1S mutation affect post-translational modification of Ubc4. It has been 
shown previously that Yap1 contains a redox active cysteine residue that causes mobility shift on 
polyacrylamide gel. To observe whether similar modification exists to Ubc4, I prepared cellular 
extracts without the use of reducing reagents. In cells expressing myc-tagged wild-type Ubc4 
(WT) or a ubc4(C2S) mutant, Ubc4 exists as two distinct bands on Western blots. In contrast, the 
ubc4(C1S) mutant exists as a single band, corresponding to the slower-mobility form of the wild-
type Ubc4 or the C1S mutant. In samples prepared in the presence of the reducing reagents DTT 
and β-mercaptoethanol, the fast-mobility form of Ubc4 disappears, suggesting that cysteine 
residue 22 of Ubc4 might be involved in redox sensing.  
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Figure 15: Post-translational modification of Ubc4 	  
Rho+ and Rho0 ubc1Δ ubc4Δ strain containing a plasmid encoding myc-tagged wild-type UBC4, 
a C1S or a C2S mutant were grown in YNBcasD or YNBcasR media and Ubc4 was analyzed for 
post-translational modification by immunoblotting. Protein preparation and SDS-PAGE were 
done using two different procedures: reducing and non-reducing. Reducing SDS-PAGE was 
carried out using the reducing reagents dithiothreitol (DTT) and β-Mercaptoethanol (BME) 
during sample preparation. For samples that received non-reducing treatment, no reducing 
reagent was used. 
Discussion 	  
In rho0 cells, where respiratory growth is not possible due to loss of components of 
oxidative phosphorylation, it is energetically favorable for cells to repress the expression of 
nuclear genes involved in respiratory metabolism for efficient use of cellular resources. Hap4, as 
the regulatory subunit of a major transcriptional activator of genes involved in oxidative 
phosphorylation and mitochondrial biogenesis, is an ideal target for this repression. Selective 
degradation of Hap4 as mediated through the UPS is largely implicated as the mechanism behind 
the decreased Hap2-5 pathway activity seen in rho0 cells. The discrepancy seen in the half-life of 
Hap4 in rho0 versus rho+ cells, which is not explained by Hap4 promoter activity, indicates a 
post-translational mechanism mediating Hap4 stability. This implicates the UPS in controlling 
the cellular response to dysfunctional mitochondria through increased degradation of Hap4.  
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Of the 13 ubiquitin-conjugating E2 enzymes encoded in the yeast genome, Ubc4 and 
Ubc5 are the main factors that mediate bulk protein degradation (Seufert & Jentsch, 1990). They 
are also involved in targeting a number of short-lived, abnormal, misfolded proteins (Glickman 
& Ciechanover, 2002). The redundant function of Ubc4 and Ubc5 is shared with Ubc1. 
However, Ubc1 has been implicated in acting mostly in the early stages of cell growth and 
therefore may have a more limited role in bulk protein degradation (Seufert, McGrath, & 
Jentsch, 1990). In this study, I found that Ubc1 and Ubc4 play a redundant role in mediating 
Hap4 degradation. Successful identification of the E2 enzymes responsible for Hap4 degradation 
through the UPS opens the gateway to research on the factors and cellular mechanisms 
regulating the selective targeting of Hap4 in response to mitochondria functional state.  
Mitochondria are a major source of reactive oxygen species (ROS), which are produced 
as byproducts of aerobic respiration. These byproducts include hydrogen peroxide (H2O2), 
hydroxyl radicals (OH-), and the superoxide radical (O2-), all of which are highly reactive and 
capable of damaging cellular components. There is a large debate in the scientific community 
over the redox environment of rho0 cells. One school of thought suggests that due to decreased 
respiratory activity, oxidative stress is reduced in cells lacking mtDNA (Chandel & Schumacker, 
1999). However, it is also argued that the cellular environment is subject to increased oxidative 
stress due to high concentrations of ROS produced due to blocks in the respiratory chain. Our 
data shown in Figure 15 suggests that Ubc4 is oxidized via cysteine residue 22 based on its 
similar modification to another well-studied protein Yap1. 
A number of short-lived proteins have been shown to be subject to increased targeting by 
Ubc4 and Ubc5 in response to oxidative stress (Medicherla & Goldburg, 2008). These enzymes 
are also the only two E2s in the yeast genome that share the highly conserved cysteine 22 and 
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108 cysteine residue (the numbering is based on Ubc4) (Figure 16). In combination with the 
enzymes’ known overlapping functions, these observations suggest these two cysteine residues 
are potential sites of regulation in response to changes in the cellular redox environment. As 
previously stated, cysteine residues are rare in proteins and are often involved in cellular redox 
sensing. This is accomplished at cysteine’s sulfhydryl group (SH), which responds to the 
oxidative state of the cell through the formation of redox sensitive bonds either to another 
cysteine residue (disulfide bonds) or is oxidized to sulfenic acid, sulfinic acid, or sulfonic acid.  
Two proteins commonly involved in redox sensing are thioredoxin and glutaredoxin, both 
of which exist in S. cerevisiae. These two proteins work in a similar manner to sense and respond 
to oxidative stress for maintaining homeostasis of the cellular environment. Yeast have two types 
of glutaredoxin proteins. The first of these consists of two oxioreductases, Grx1 and Gx2, both of 
which contain two highly conserved redox-active cysteine residues. These proteins catalyze the 
formation of protein mixed disulfides with glutathione, a prevalent cysteine modification 
(Mieyal, Gallogly, Qanungo, Sabens, & Shelton). The other is a fairly novel group of three 
proteins (Grx3,Grx4, and Grx5), which contain only a single active cysteine residue  (Collinson, 
Wheeler, Garrido, Avery, Avery, & Grant, 2002). As a mechanism catalyzed by a number of 
highly conserved enzymes, further insight on the factors controlling the regulation of this system 
has large implications in research on disease states such as diabetes, cancer, cardiovascular and 
lung disease, and neurodegenerative disease (Mieyal, Gallogly, Qanungo, Sabens, & Shelton, 
2008).  This is particularly relevant due to the fact that oxidative stress is a ubiquitous occurrence 
in all aerobic growing organisms, leading to conservation in the cellular responses to oxidative 
damage (Jamieson, 1998).   
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The fast migrating band seen in wild-type Ubc4 and the ubc4(C2S) mutant in Figure 15 is 
similar to what is observed for Yap1, a transcription factor that is activated in response to 
oxidative stress (Delaunay, Isnard, & Toledano, 2000). In Dr. Delaunay’s paper on Yap1’s role 
in H2O2 sensing, evidence was provided for two conserved cysteine residues as playing a central 
role in Yap1’s in vivo oxidation. In their research, an unknown cause results in the redox-
dependent migration shift of Yap1 when run on non-reducing PAGE after treatment with H2O2, 
but not with other oxidants (Delaunay, Isnard and Toledano, 2000). A similar model can be 
proposed for Ubc4, whereby an unknown mechanism leads to oxidation of Ubc4 at cysteine 
residue 22. 
The research presented here has deep implications for the redox-sensing properties of 
Ubc4, possibly through the redox-sensitive cysteine residue 22, as contributing to the regulation 
of Hap2-5 pathway activity. Based on these findings, a novel model for Hap4 regulation can be 
proposed, whereby the steady-state level of Hap4 is regulated through the redox regulation of 
Ubc4. 
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Figure 16: Sequence Alignment of Yeast’s Thirteen Ubc Enzymes  
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Conclusion 	  
The results of my research implicate post-translational regulation of Hap4 through the 
UPS as the underlying mechanism regulating Hap4 levels in response to changes in 
mitochondrial functional state. In this work, the isolation of the ubiquitin-conjugating enzymes 
responsible for Hap4 degradation provides a novel mechanism for the regulation of 
mitochondrial biogenesis in response to changes in the functional state of mitochondria. Through 
mutant screening, the ubiquitin conjugating-enzymes, Ubc1 and Ubc4, were found to be the 
primary E2s responsible for increased Hap4 instability in rho0 cells and subsequent down-
regulation of Hap2-5 target genes. Mutant analyses of two highly conserved cysteine residues of 
Ubc4 led us to propose that regulation of Hap4 stability in response to changes in the cellular 
respiratory function is mediated through redox-regulation of Ubc4. 
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